Have Questions?

Global Headquarters

Tel: +44 (0)20 7377 0800
Fax: +44 (0)20 7349 5157

North America

Tel: 1-617-573-9450
Fax: 1-617-573-9542

Japan

Tel: +81 (0)80-1164-4754

Request a Demo

What our customers are saying

When I think of the future, I think of EvaluatePharma

Senior Director,
Global pharmaceutical company

EvaluateMedTech World Preview 2016, Outlook to 2022

Worldwide Medtech Sales Forecast to Reach $529.8 Billion by 2022

Pharmaceutical Innovation in Europe Pharmaceutical Innovation in Europe Pharmaceutical Innovation in Europe

Download Report

The total value of the global medtech market is expected to reach $529.8 billion by 2022, growing at an annual rate of 5.2 percent over the next seven years according to the EvaluateMedTech World Preview 2016, Outlook to 2022 report.

The report also found that worldwide medtech R&D expenditure is forecast to grow by 4.3% per annum to reach $34.0 billion by 2022.

Key highlights:

  • Worldwide medtech sales forecast to reach $529.8bn by 2022
  • Medtronic remains top medtech company in 2022; sales forecast to reach $39.9bn
  • M&A activity in H1 2016 slumps 79% to $17bn following 2015’s flurry of mega mergers
  • Medtech R&D spend forecast to grow by 4.3% per annum to $34.0bn in 2022
  • Number of first-time PMAs and HDEs hits a ten-year high in 2015; 510(k) clearances decrease 6% to 3,064

View Infographic

Report Executive Summary

Press Release


Confirm your details on form below to download this report